Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
6,208,589
-
Share change
-
+3,491,299
-
Total reported value
-
$129,016,000
-
Price per share
-
$20.78
-
Number of holders
-
45
-
Value change
-
+$73,086,744
-
Number of buys
-
38
-
Number of sells
-
7
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q4 2018
As of 31 Dec 2018,
Krystal Biotech, Inc. - COMMON STOCK (KRYS) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,208,589 shares.
The largest 10 holders included
FMR LLC, FRAZIER MANAGEMENT LLC, BAKER BROS. ADVISORS LP, GREAT POINT PARTNERS LLC, Vanguard Group Inc, CITADEL ADVISORS LLC, Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Knoll Capital Management, LP, and Artal Group S.A..
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.